Egas Moniz Center for Interdisciplinary Research (CiiEM), Egas Moniz School of Health & Science, Monte da Caparica, Almada, Portugal.
UCIBIO/i4HB- Applied Molecular Biosciences Unit, NOVA School of Science and Technology, NOVA University of Lisbon, Caparica, Portugal.
Clin Oral Investig. 2024 Sep 12;28(10):521. doi: 10.1007/s00784-024-05913-x.
In this review, we explored potential associations between NO and its derivatives, nitrite and nitrate, with periodontal and cardiovascular diseases, with special emphasis on the former. By providing a state-of-the-art and integrative understanding of this topic, we aimed to shed light on the potential role of these three nitrogen oxides in the periodontitis-hypertension nexus, identify knowledge gaps, and point out critical aspects of the experimental methodologies.
A comprehensive literature review was conducted on human salivary and plasma concentrations of nitrate and nitrite, and their impact on periodontal and cardiovascular health.
A nitrate-rich diet increases nitrate and nitrite levels in saliva and plasma, promoting oral health by favorably altering the oral microbiome. Chlorhexidine (CHX) mouthrinses disrupt the nitrate-nitrite-NO pathway, reducing NO bioavailability, and potentially affecting blood pressure. This is because CHX eliminates nitrate-reducing bacteria, which are essential for NO production. Although endogenous NO production may be insufficient, the nitrate-nitrite-NO pathway plays a critical role in maintaining appropriate endothelial function, which is balanced by the microbiome and dietary nitrate intake. Dietary nitrate supplementation may lead to beneficial changes in the oral microbiome, thereby increasing the NO bioavailability. However, NO bioavailability can be compromised by reactive oxygen species (ROS) and the uncoupling of endothelial nitric oxide synthase (eNOS), leading to further ROS generation and creating a detrimental cycle. Studies on NO and periodontal disease have shown increased nitrite concentrations in patients with periodontal disease, although these studies have some methodological limitations. In terms of blood pressure, literature suggests that CHX mouthrinses may reduce the capacity of nitrate-reducing bacteria, potentially leading to an increase in blood pressure.
Several studies have suggested an association between NO levels and the development of cardiovascular and periodontal diseases. However, the exact mechanisms linking these diseases remains to be fully elucidated.
Nitric oxide (NO) is a signaling molecule that plays a crucial role in several physiological processes such as vascular homeostasis, inflammation, immune cell activity, and pathologies such as hypertension and periodontitis.
在本综述中,我们探讨了一氧化氮(NO)及其衍生物亚硝酸盐和硝酸盐与牙周病和心血管疾病之间的潜在关联,特别关注前者。通过提供该主题的最新和综合理解,我们旨在阐明这三种氮氧化物在牙周炎-高血压关联中的潜在作用,确定知识空白,并指出实验方法的关键方面。
对人类唾液和血浆中硝酸盐和亚硝酸盐的浓度及其对牙周和心血管健康的影响进行了全面的文献综述。
富含硝酸盐的饮食会增加唾液和血浆中的硝酸盐和亚硝酸盐水平,通过有利地改变口腔微生物组来促进口腔健康。洗必泰(CHX)漱口水会破坏硝酸盐-亚硝酸盐-NO 途径,降低 NO 的生物利用度,并可能影响血压。这是因为 CHX 消除了产生 NO 所必需的硝酸盐还原菌。尽管内源性 NO 产生可能不足,但硝酸盐-亚硝酸盐-NO 途径在维持适当的内皮功能方面起着关键作用,而这一功能又受到微生物组和饮食中硝酸盐摄入量的平衡。饮食中补充硝酸盐可能会导致口腔微生物组发生有益变化,从而增加 NO 的生物利用度。然而,活性氧(ROS)和内皮型一氧化氮合酶(eNOS)的解偶联会使 NO 的生物利用度受到损害,导致进一步的 ROS 生成,并形成一个有害的循环。关于 NO 和牙周病的研究表明,牙周病患者的亚硝酸盐浓度增加,尽管这些研究存在一些方法学上的局限性。关于血压,文献表明 CHX 漱口水可能会降低硝酸盐还原菌的能力,从而可能导致血压升高。
几项研究表明,NO 水平与心血管和牙周疾病的发生之间存在关联。然而,将这些疾病联系起来的确切机制仍有待充分阐明。
一氧化氮(NO)是一种信号分子,在血管稳态、炎症、免疫细胞活性以及高血压和牙周炎等疾病等多种生理过程中发挥着关键作用。